A breast cancer targetingpeptide, EPPT, against underglycosylated mucin-1, promotes preferentialendocytosis of NEMO particles by malignant cells and specific activationof the MRI signal inside low pH endosomes/lysosomes. Here, MUC1 is linked to breast carcinoma.